Payment overview · 2025
General Payments
$25.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Hector R Toro, MD
Allopathic & Osteopathic Physicians|Family Medicine · LAS PIEDRAS, PR · NPI 1114033990
Verified facts
What the public records show
CMS Open Payments records show Hector R Toro, MD received $25.00 in general payments during 2025 across 1 reported records.
Eli Lilly Export S.A. Puerto Rico Branch accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | Unresolved — no canonical attribution shown | $25.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $25.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ZEPBOUND Normalized: zepbound |
Drug | Eli Lilly Export S.A. Puerto Rico Branch | $25.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1088 | 285 |
| Synthroid | Levothyroxine Sodium | 895 | 202 |
| Montelukast Sodium | Montelukast Sodium | 856 | 304 |
| Famotidine | Famotidine | 715 | 208 |
| Gabapentin | Gabapentin | 691 | 185 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 675 | 190 |
| Losartan Potassium | Losartan Potassium | 605 | 154 |
| Ezetimibe | Ezetimibe | 539 | 152 |
| Diclofenac Sodium | Diclofenac Sodium | 536 | 180 |
| Metformin Hcl | Metformin Hcl | 520 | 133 |
| Amlodipine Besylate | Amlodipine Besylate | 506 | 130 |
| Fluticasone Propionate | Fluticasone Propionate | 506 | 173 |
| Simvastatin | Simvastatin | 504 | 127 |
| Omeprazole | Omeprazole | 446 | 132 |
| Pantoprazole Sodium | Pantoprazole Sodium | 417 | 116 |
| Baclofen | Baclofen | 337 | 134 |
| Levothyroxine Sodium | Levothyroxine Sodium | 324 | 86 |
| Metoprolol Succinate | Metoprolol Succinate | 307 | 79 |
| Allopurinol | Allopurinol | 300 | 86 |
| Lisinopril | Lisinopril | 272 | 76 |
| Clonazepam | Clonazepam | 251 | 57 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 245 | 90 |
| Clopidogrel | Clopidogrel Bisulfate | 244 | 65 |
| Tizanidine Hcl | Tizanidine Hcl | 211 | 57 |
| Meloxicam | Meloxicam | 207 | 68 |
| Pravastatin Sodium | Pravastatin Sodium | 204 | 56 |
| Pioglitazone Hcl | Pioglitazone Hcl | 202 | 56 |
| Alendronate Sodium | Alendronate Sodium | 194 | 52 |
| Prednisone | Prednisone | 190 | 147 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 188 | 55 |
| Nabumetone | Nabumetone | 181 | 64 |
| Irbesartan | Irbesartan | 174 | 52 |
| Pregabalin | Pregabalin | 174 | 26 |
| Tamsulosin Hcl | Tamsulosin Hcl | 172 | 46 |
| Ketoconazole | Ketoconazole | 169 | 88 |
| Temazepam | Temazepam | 167 | 37 |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 163 | 41 |
| Doxazosin Mesylate | Doxazosin Mesylate | 158 | 40 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 156 | 36 |
| Hydrochlorothiazide | Hydrochlorothiazide | 153 | 44 |
| Lansoprazole | Lansoprazole | 141 | 31 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 140 | 50 |
| Candesartan Cilexetil | Candesartan Cilexetil | 133 | 36 |
| Diclofenac Potassium | Diclofenac Potassium | 123 | 47 |
| Fenofibric Acid | Fenofibric Acid (Choline) | 122 | 32 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 117 | 70 |
| Farxiga | Dapagliflozin Propanediol | 116 | 31 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 106 | 27 |
| Tramadol Hcl | Tramadol Hcl | 104 | 34 |
| Eliquis | Apixaban | 103 | 19 |
| Meclizine Hcl | Meclizine Hcl | 99 | 45 |
| Etodolac | Etodolac | 96 | 32 |
| Azithromycin | Azithromycin | 91 | 79 |
| Raloxifene Hcl | Raloxifene Hcl | 91 | 28 |
| Humulin N | Insulin Nph Human Isophane | 88 | 16 |
| Januvia | Sitagliptin Phosphate | 86 | 22 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 84 | 17 |
| Enalapril Maleate | Enalapril Maleate | 83 | 18 |
| Ibandronate Sodium | Ibandronate Sodium | 78 | 28 |
| Duloxetine Hcl | Duloxetine Hcl | 77 | 23 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 77 | 19 |
| Finasteride | Finasteride | 72 | 18 |
| Trulicity | Dulaglutide | 71 | 18 |
| Metoclopramide Hcl | Metoclopramide Hcl | 69 | 23 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 65 | 33 |
| Levofloxacin | Levofloxacin | 62 | 54 |
| Donepezil Hcl | Donepezil Hcl | 61 | 25 |
| Sildenafil Citrate | Sildenafil Citrate | 59 | 18 |
| Carvedilol | Carvedilol | 58 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 58 | 52 |
| Lorazepam | Lorazepam | 58 | 12 |
| Xarelto | Rivaroxaban | 57 | 12 |
| Linzess | Linaclotide | 55 | 11 |
| Folic Acid | Folic Acid | 54 | 12 |
| Atenolol | Atenolol | 53 | 16 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 51 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 51 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 48 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 48 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 48 | suppressed |
| Memantine Hcl | Memantine Hcl | 47 | 18 |
| Sertraline Hcl | Sertraline Hcl | 47 | 15 |
| Furosemide | Furosemide | 46 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 45 | 37 |
| Sure Comfort | Syringe And Needle,insulin,1ml | 44 | 11 |
| Valsartan | Valsartan | 44 | 13 |
| Glipizide Er | Glipizide | 43 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 42 | 12 |
| Metoprolol Tartrate | Metoprolol Tartrate | 42 | 12 |
| Ramipril | Ramipril | 40 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | 19 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | suppressed |
| Telmisartan | Telmisartan | 38 | suppressed |
| Ciclopirox | Ciclopirox | 36 | 23 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 36 | 20 |
| Sucralfate | Sucralfate | 36 | 14 |
| Alprazolam | Alprazolam | 35 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 34 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 20 |
| Metformin Hcl Er | Metformin Hcl | 33 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 33 | 33 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 32 | 13 |
| Celecoxib | Celecoxib | 32 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | suppressed |
| Ibuprofen | Ibuprofen | 32 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Rivastigmine | Rivastigmine | 32 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 30 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 30 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 29 | suppressed |
| Jardiance | Empagliflozin | 29 | 13 |
| Latanoprost | Latanoprost | 29 | suppressed |
| Methotrexate | Methotrexate Sodium | 29 | 11 |
| Glipizide | Glipizide | 28 | suppressed |
| Verapamil Er | Verapamil Hcl | 28 | suppressed |
| Cefadroxil | Cefadroxil | 27 | 24 |
| Colchicine | Colchicine | 27 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 27 | suppressed |
| Lidocaine | Lidocaine | 27 | suppressed |
| Spironolactone | Spironolactone | 27 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 27 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 27 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 26 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 26 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 26 | 21 |
| Glycopyrrolate | Glycopyrrolate | 25 | 12 |
| Buspirone Hcl | Buspirone Hcl | 24 | 11 |
| Clindamycin Hcl | Clindamycin Hcl | 24 | 23 |
| Symbicort | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Naproxen | Naproxen | 23 | 12 |
| Topiramate | Topiramate | 23 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 22 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 22 | 15 |
| Ammonium Lactate | Ammonium Lactate | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 18 |
| Bupropion Xl | Bupropion Hcl | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 20 | suppressed |
| Glimepiride | Glimepiride | 19 | suppressed |
| Mirtazapine | Mirtazapine | 19 | suppressed |
| Piroxicam | Piroxicam | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Etodolac Er | Etodolac | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 17 |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 18 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 15 |
| Ibu | Ibuprofen | 17 | suppressed |
| Lumigan | Bimatoprost | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 16 | 14 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 15 | suppressed |
| Desonide | Desonide | 15 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Easy Touch Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Olanzapine | Olanzapine | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 14 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 14 | suppressed |
| Lamotrigine | Lamotrigine | 14 | suppressed |
| Mupirocin | Mupirocin Calcium | 14 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 14 | 14 |
| Risperidone | Risperidone | 14 | suppressed |
| Tadalafil | Tadalafil | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 12 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 12 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 12 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Carbamazepine | Carbamazepine | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Eletriptan Hbr | Eletriptan Hydrobromide | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 11 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 11 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Procto-Med Hc | Hydrocortisone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25.00 · 1 records | Eli Lilly Export S.A. Puerto Rico Branch | ZEPBOUND | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error